ACB
$12.040 (0.67%)
ACNNF
$0.152 (1.33%)
AERO
$3.000 (0.33%)
AGEEF
$0.071 (-11.43%)
ALEAF
$0.642 (-2.79%)
AMMJ
$0.150 (30.15%)
APHA
$12.420 (2.56%)
ARNA
$80.500 (-0.07%)
ATT:CNX
$0.080 (0%)
ATTBF
$0.014 (8.46%)
AUSA:CNX
$0.510 (15.91%)
AUSAF
$0.409 (14.54%)
AVXL
$5.820 (-1.69%)
BAMM:CNX
$0.680 (-1.45%)
BBM:CNX
$0.125 (-3.85%)
BBRRF
$0.101 (-1.98%)
BE:CNX
$0.005 (0%)
BIO:CNX
$0.055 (10%)
BLEVF
$0.005 (-4.08%)
BLIS:CNX
$0.315 (0%)
BLO:CNX
$1.190 (-5.56%)
BLOZF
$0.940 (-4.77%)
BUDZ
$0.398 (12.27%)
BXNG
$0.520 (0%)
CADMF
$0.691 (0.1%)
CALI:CNX
$0.100 (-9.09%)
CANN
$0.618 (3.1%)
CARA
$18.560 (2.83%)
CBWTF
$0.298 (-0.68%)
CGC
$33.390 (-3.55%)
CGRW
$0.280 (36.59%)
CHOO:CNX
$0.080 (-11.11%)
CHOOF
$0.063 (-11.96%)
CNBX
$0.325 (16.04%)
CNGGF
$0.460 (0%)
CODI
$21.450 (0.94%)
CPMD
$0.440 (-8.33%)
CRBP
$1.740 (0%)
CRON
$10.930 (-2.93%)
CROP:CNX
$0.015 (0%)
CRTPF
$2.670 (-1.48%)
CRXPF
$0.024 (2.17%)
CSI:CNX
$0.920 (0%)
CURR
$1.300 (-2.99%)
CVSI
$0.625 (-0.79%)
DIGP
$0.047 (-1.37%)
DXBRF
$0.169 (5.31%)
EAPH
$0.001 (0%)
EAT:CNX
$0.015 (0%)
EEVVF
$0.038 (0%)
EMHTF
$0.198 (-0.96%)
EPWCF
$0.253 (-2.2%)
EVIO
$0.008 (16.94%)
FFRMF
$0.059 (3.54%)
FFT:CNX
$0.040 (0%)
FNNZF
$0.082 (5.15%)
GGTTF
$0.117 (12.5%)
GLDFF
$0.023 (-3.77%)
GLH:CNX
$0.030 (20%)
GNBT
$0.287 (-6.52%)
GRIN:CNX
$0.105 (-8.7%)
GRWG
$51.110 (1.25%)
GTBIF
$28.150 (-6.21%)
GTII:CNX
$35.900 (-5.28%)
GWPH
$135.730 (-1.52%)
HEXO
$7.210 (1.12%)
HHPHF
$0.008 (0%)
HLSPY
$0.384 (1.05%)
HMLSF
$8.700 (-0.57%)
HMPPF
$0.498 (0%)
HRVOF
$0.083 (8.78%)
HSTRF
$0.340 (-1.54%)
HUGE:CNX
$2.630 (1.15%)
IAN:CNX
$0.400 (2.56%)
IGC
$1.530 (-1.29%)
IGXT
$0.265 (0.91%)
IIPR
$189.300 (-0.25%)
INQD
$0.004 (0%)
IONC:CNX
$0.040 (14.29%)
IONKF
$0.033 (8.62%)
ISOL:CNX
$0.035 (0%)
ISOLF
$0.070 (-14.32%)
ITHUF
$0.313 (1.13%)
IVITF
$0.019 (-15.56%)
JWCAF
$0.014 (0%)
KALTF
$0.001 (0%)
KBEV:CNX
$0.060 (0%)
KBEVF
$0.050 (0%)
KHRNF
$0.305 (-4.72%)
KSHB
$1.360 (9.68%)
LHS:CNX
$1.210 (-5.47%)
LHSIF
$0.945 (-5.32%)
LOVE:CNX
$0.135 (0%)
LXLLF
$0.001 (0%)
LXX:CNX
$5.780 (2.3%)
MCIG
$0.028 (0%)
MEDIF
$0.604 (-8.45%)
MGWFF
$0.054 (-0.22%)
MICWF
$0.115 (-18.24%)
MJ:CNX
$0.560 (7.69%)
MJNA
$0.025 (-2.69%)
MNTR
$0.130 (5.78%)
MRRCF
$0.005 (9.76%)
MYM:CNX
$0.105 (-4.55%)
MYMMF
$0.086 (3.01%)
NCNNF
$0.186 (8.14%)
NDVAF
$0.343 (-5.36%)
NGW:CNX
$0.640 (18.52%)
NRXCF
$0.096 (3.35%)
NSPDF
$0.052 (24.04%)
NTEC
$4.130 (-4.84%)
NVTQF
$0.211 (0%)
NWKRF
$0.424 (0%)
NXGWF
$0.505 (17.73%)
NXTTF
$0.259 (-21.49%)
OH:CNX
$5.330 (0%)
ORHOF
$4.050 (0%)
OWCP
$0.011 (-13.71%)
PHCG
$0.490 (11.36%)
PHVAF
$0.038 (0%)
PILL:CNX
$0.830 (3.75%)
PKG:CNX
$0.155 (-3.13%)
PLPRF
$0.704 (-1.19%)
PLUS:CNX
$0.900 (-1.1%)
PMCB
$0.015 (6.62%)
PNPL
$0.085 (0%)
POTN
$0.008 (-4.94%)
PRCNF
$0.011 (12%)
PTNYF
$0.119 (-2.46%)
QCA:CNX
$0.195 (0%)
RDDTF
$0.077 (-6.98%)
RLLVF
$0.029 (-12.05%)
RMHB
$0.032 (-4.48%)
RQB:CNX
$0.005 (0%)
RQHTF
$0.325 (2.34%)
RVVQF
$0.008 (0%)
SLNG:CNX
$0.435 (4.82%)
SMG
$220.890 (-1.37%)
SNN:CNX
$0.155 (0%)
SNNVF
$0.050 (0.1%)
SOL:CNX
$3.450 (0%)
SOLCF
$2.716 (-0.87%)
SPLIF
$0.009 (-21.74%)
SPRWF
$0.168 (0.66%)
SRNA
$0.130 (-34.97%)
STEM:CNX
$0.660 (0%)
STMH
$0.515 (-0.97%)
SUN:CNX
$0.160 (0%)
TBPMF
$0.155 (-1.21%)
TCAN:CNX
$0.850 (-4.49%)
TCNAF
$0.672 (-10.29%)
TER:CNX
$17.220 (-1.37%)
TGEN
$1.610 (-10.56%)
TGIF:CNX
$0.095 (5.56%)
TGIFF
$0.076 (5.98%)
THC:CNX
$0.110 (-8.33%)
THCBF
$0.085 (-3.92%)
TLRY
$19.700 (6.14%)
TOKI:CNX
$0.015 (0%)
TRLFF
$0.445 (8.44%)
TRSSF
$13.550 (-1.6%)
TRTC
$0.307 (-2.15%)
TURV
$0.055 (-1.89%)
VBIO
$0.060 (-4.76%)
VIDA:CNX
$0.055 (0%)
VIN:CNX
$0.065 (0%)
VPRB
$0.029 (25.99%)
VRNDF
$0.426 (-0.91%)
VRT:CNX
$0.150 (0%)
VRTHF
$0.115 (0%)
VVCIF
$0.140 (-2.51%)
WAYL:CNX
$0.740 (0%)
WDDMF
$0.272 (7.58%)
WLDFF
$0.124 (-4.85%)
XXII
$2.780 (-2.46%)
ZDPY
$0.400 (0.03%)
ZYNE
$3.590 (-1.64%)
Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, and CTT Pharmaceutical Holdings, Inc., ("CTT") (OTC | CTTH) announced today the successful commercialization of CTT's cannabinoid-infused sublingual wafers. The new cannabis product line, a first of its kind, has been launched by…
RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), one of Canada’s most innovative cannabis producers, announces that it has received a permit from Health Canada to allow the Company to export cannabis to Australia. The permit allows for the export of dried cannabis flower from the…
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has completed the construction of its Paris Processing facility’s Phase II expansion and secured full site occupancy on October 4, 2019, following the successful completion of County of Brant inspections. The Paris Phase II expansion is…
Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today provided a corporate update on its global operations, business units, and portfolio of strategic investments. As a global leader in cannabis revenues, cannabis production, research, innovation, and international market…
The Board of Directors of Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has appointed Lea Ray as its new Lead Independent Director. As previously announced on April 4, 2019, the role rotates among independent directors every six months, as determined by a majority…
Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT) is pleased to announce that it is actively pursuing a product development collaboration with International Flavors & Fragrances Inc. (NYSE: IFF) to co-develop hemp-derived CBD products for the U.S. market. "IFF is a well-recognized leader and innovator in…
SMITHS FALLS, ON and TORONTO, Oct. 2, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to announce that it has completed an all-cash transaction to purchase a majority stake in BioSteel Sports Nutrition Inc. ("BioSteel"), a leading producer of sports nutrition products.…
VANCOUVER, Sept. 30, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced that it has entered into a definitive agreement (the "Agreement") with PAX Labs, Inc. ("PAX"), under which Zenabis will supply cannabis extracts for PAX Era Pods designed for use with the PAX Era vaporizer device. This…
Canadian Licensed Producers (LPs) have been heavily impacted by the recent weakness in the cannabis sector and this is a trend that we continue to follow. Although the entire sector has been under pressure, Canadian LPs have been some of the hardest hit and we believe that a number of…
VICTORIA, British Columbia, July 30, 2019 -- Emerald Health Therapeutics, Inc. “Emerald” (TSXV: EMH; OTCQX: EMHTF) has appointed Riaz Bandali as Chief Executive Officer. Mr. Bandali has over 25 years of experience in life sciences, with expertise in global operations, strategy development, innovation cultivation, M&A, and investment management spanning contract…